Evidence map›Paper›PMID 29361085›Full record

ArticleInflammatory bowel diseases2018

The Influence of Hormonal Fluctuation on Inflammatory Bowel Disease Symptom Severity-A Cross-Sectional Cohort Study.

Vineet S Rolston, Laleh Boroujerdi, Millie D Long, Dermot P B McGovern, Wenli Chen, Christopher F Martin, Robert S Sandler, John D Carmichael, Marla Dubinsky, Gil Y Melmed

Open access · bronzeAbstract read
In one paragraph

Article in Inflammatory bowel diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease.The European journal of health economics : HEPAC : health economics in prevention and care · 2024
    Trial
  4. Article
  5. Review
  6. Review
  7. Review
  8. Patterns and Predictors of Steroid Use in a Real-World Inflammatory Bowel Disease Cohort.JGH open : an open access journal of gastroenterology and hepatology · 2025
    Article
  9. Review
  10. Article
  11. Review
  12. Gut Microbiome and Estrogen.Journal of menopausal medicine · 2025
    Review
  13. Influence of biological sex in inflammatory bowel diseases.Nature reviews. Gastroenterology & hepatology · 2025
    Review
  14. Article
  15. Sex hormone deprivation abolishes sex-specific differences in murine colon inflammation and related lipid mediator production.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  16. Contraception in Medically Complex Adolescents and Young Adults.Open access journal of contraception · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Vineet S RolstonF.Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles.
Laleh BoroujerdiUCLA, Olive View Medical Center, Los Angeles.
Millie D LongDivision of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill.
Dermot P B McGovernF.Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles.
Wenli ChenDivision of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill.
Christopher F MartinSusan and Leonard Feinstein IBD Center, Icahn School of Medicine, Mount Sinai New York.
Robert S SandlerDivision of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill.
John D CarmichaelF.Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles.
Marla DubinskySusan and Leonard Feinstein IBD Center, Icahn School of Medicine, Mount Sinai New York.
Gil Y MelmedF.Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles.
Cedars-Sinai Medical Center · USUniversity of North Carolina at Chapel Hill · USIcahn School of Medicine at Mount Sinai · USOlive View-UCLA Medical Center · US

Funding

PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Temitope O. Keku · 1985 to 2026
$30.5M
NIDDK NIH HHS P30 DK034987
6 · The paper itself

Abstract

Background: Many women with inflammatory bowel disease (IBD) report changes in symptoms in association with hormonal changes during menses, pregnancy, and hormonal contraceptive use, suggesting a hormonal influence on disease activity. We aimed to identify and characterize IBD symptom fluctuations in women during times of hormonal variation. Methods: From June 2012 through September 2012, women enrolled in Crohn's and Colitis Foundation of America Partners , an online Internet cohort of patients with IBD, were invited to participate in this study. Using a 5-point Likert scale, participants were asked to rate symptom changes during their menstrual cycle, pregnancy, the postpartum period, and after menopause. Clinical and demographic differences were assessed using univariate and multivariable methods. Results: A total of 1,203 female patients with Crohn's disease (CD) and ulcerative colitis (UC) participated (64% CD, 34% UC). Over half of the women with IBD reported worsening symptoms during menses. Symptom changes were similar between women with CD vs UC, except in pregnancy, where symptom worsening during pregnancy was more commonly seen in UC than CD (P = 0.02). Overall, women reporting symptom worsening were younger at the time of IBD diagnosis (P < 0.01), had lower quality of life (SIBDQ) scores (P < 0.01), and had a higher BMI (25 vs 24) than women without symptom worsening. Conclusions: Women with IBD report changes in symptom severity during times of hormone fluctuation. Further clarification of the role of hormones in IBD is warranted in order to understand these relationships and to identify potential management strategies for women with IBD and hormonally sensitive gastrointestinal symptoms.

Indexed as

AdultCohort StudiesCross-Sectional StudiesFemaleHumansInflammatory Bowel DiseasesMenopauseMenstruationMiddle AgedMultivariate AnalysisPostpartum PeriodPregnancyQuality of LifeRegression AnalysisSeverity of Illness IndexSurveys and QuestionnairesCrohn’s diseasehormonal fluctuationinflammatory bowel disease (IBD)ulcerative colitis

Identifiers

PMID29361085
PMCPMC6196767
OpenAlexW2793421678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.